ArticleOncogene2022
Targeting glutamine metabolism network for the treatment of therapy-resistant prostate cancer.
Lingfan Xu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
25 papers cite it
this papercites it
ArticleOncogene2022
Lingfan Xu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.